Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    As the city prepares for a season of celebration Longevity Hub by Clinique La Prairie at One&Only; One Za’abeel invites guests to indulge in its most-loved rejuvenating treatments, carefully selected to help skin glow before the celebrations and recover with ease afterward. Before the holidays, the focus turns to radiance. Treatments such as the La Prairie […] The post Longevity Hub by Clinique La Prairie’s Expert Recommendations for Pre- and Post-Festive Skin Rejuvenation appeared first on Web-Release.